Evidence map

ReviewBioscience reports2019

Cardiovascular risk of sitagliptin in treating patients with type 2 diabetes mellitus.

De-Kang Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

5 papers cite it

2019
2020
2021
2022
2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 31262972